
Trump targets drug imports with steep tariffs. India’s pharma firms could take the blow.
U.S. President Donald Trump’s decision to impose 100% tariffs on branded and patented drug imports starting Oct. 1 could hit India’s pharmaceutical industry hard. The U.S. is India’s largest market, accounting for $8.7 billion of exports in FY24, or 31% of total shipments. Indian firms supply more than 45% of America’s generics and 15% of […]